Cancer uses a little-understood element of cell signaling to hijack the communication process and spread, according to Rice University researchers. A new computational study by researchers at the Rice-based Center for Theoretical Biological...Show More Summary
Documenting Loss: Eugene Richards made portraits of Dorothea Lynch during her cancer treatment. For years, photographers have been bringing Photographic Center Northwest executive director Michelle Dunn Marsh pictures of dead bodies—people, mostly, but some animals, too. Show More Summary
Deepa Bhojwani, MD, joins Children's Hospital Los Angeles (CHLA) as director of the Leukemia/Lymphoma program within the Children's Center for Cancer and Blood Diseases on February 15, 2015.
A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.
The Fred Hutchinson Cancer Research Center Bone Marrow Transplant Program at Seattle Cancer Care Alliance (SCCA) was recently recognized for outperforming its anticipated one-year survival rate for allogeneic transplant patients. The...Show More Summary
Seattle Cancer Care Alliance Proton Therapy, A ProCure Center is proud to announce the additions of Patti Brooke and Jason Dixon to the Seattle team. Brooke joins the team as vice president of marketing and business development leading the Center's strategic plan and ongoing marketing initiatives. Show More Summary
The director of a Columbia University cancer center has been removed from his position, after a criminal complaint revealed he allegedly referred patients to embattled State Assembly Speaker Sheldon Silver in exchange for state grant money. [ more › ]
) Using a simple camera and water tank, investigators from Dartmouth-Hitchcock's Norris Cotton Cancer Center demonstrated that induced Cherenkov light can be imaged and used to confirm that the complex spatial dose distribution imparted in dynamic treatment plans is being delivered correctly.
Pancreatic cancer is often lethal, with fewer than a third of patients surviving even early stage disease. New research from the University of Michigan Comprehensive Cancer Center helps explain why this is the case. The researchers found a gene known to be involved in nearly 90 percent of pancreatic cancers promotes cancer growth and spread. The […]
CBS News medical contributor Dr. David Agus speaks with Dr. Jose Baselga, physician-in-chief and chief medical officer of Memorial Sloan Kettering Cancer Center, about the future of cancer treatment and genome mapping.
Dana-Farber Cancer Institute is expanding its research footprint, occupying portions of five floors at Longwood Center, 360 Longwood Avenue in Boston, MA, beginning later this month.
For most organizations, Big Data is still a future technology. In medicine, and in particular for major medical centers that combine advanced treatment of genetic diseases such as cancer with research, it is a present-day reality. The grainy grey-scale snapshots produced … Continue reading ?
Researchers at the University of Michigan Comprehensive Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored. This analysis opens the door to discovery of thousands of potential new cancer biomarkers.
The University of Texas MD Anderson Cancer Center was presented the People's Republic of China International Science and Technology Cooperation Award at a ceremony held Jan. 9 at Beijing's Great Hall of the People.
Elizabeth Jaffee, M.D., a pioneer in the field of vaccine therapy for pancreatic cancer, and an internationally-recognized leader in immunology research, has been appointed deputy director of the Johns Hopkins Kimmel Cancer Center. Jaffee,...Show More Summary
In a new study researchers at the UCLA Jonsson Comprehensive Cancer Center have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.
Cancer diagnosis and treatment decisions are often hampered by a lack of knowledge of the biological processes occurring within the tumor. Moffitt Cancer Center researchers have developed a new approach to analyze these processes with a technique called proximity ligation assays (PLA). Show More Summary
New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.
Richard Lauer, MD, FACP and Melanie Royce, MD, PhD, both at the University of New Mexico Cancer Center, were recently named to national task forces under the NCI's new clinical trials structure, the National Clinical Trials Network.
A new study from researchers at the University of Michigan Comprehensive Cancer Center characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.